EBMT-EHA CAR-T 2019 | EMA regulation of CAR T-cell therapy

Martina Schüßler-Lenz

Martina Schüßler-Lenz, MD European Medicines Agency, London, UK, talks through the regulation process involved in the approval of CAR T-cell therapy. Dr Schüßler-Lenz was speaking from the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video